Articles On Polynovo (ASX:PNV)

Highlights Short interest stays active across ASX mining and tech shares Rare earth and uranium companies remain under close watch Several ASX consumer and financial stocks attract renewed attention Short selling activ...

Highlights Uranium, healthcare, retail, and biotech shares are facing renewed market scrutiny across the Australian equities landscape. Several heavily watched companies are dealing with operational pressure, softer sentiment, and ongo...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

ASX 200 finishes barely higher after a choppy, headless-chook kinda sesh CBA rebounds while BHP and Rio Tinto notch fresh record highs… again CSL sinks deeper, Coles gets whacked by the ACCC and Megaport rockets on AI deals   You NO DOUBT...

PolyNovo Limited responded to an ASX price query on 14 May 2026 after its share price jumped from a low of $1.01 at close on 13 May to a high of $1.19 the following day, accompanied by a significant spike in trading volume. The Australian S...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

ASX healthcare companies working to reduce costly and ongoing challenge of post-surgery complications  Optiscan’s confocal endomicroscopic imaging tech is designed to help surgeons remove tumours with clear margins the first time Wound c...

The team at Morgans have run the ruler over two very different companies in the past few days and come out with a buy recommendation for each. Let's have a look at what stocks they like at the moment. Polynovo Ltd (ASX: PNV) This...

Alzheimer’s disease research is burgeoning – and Actinogen Medical is one of the most advanced players EBR Systems’ limited US rollout approach was a Wise move Amid increased sales, Neuren Pharmaceuticals mulls a franked dividend   No few...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Highlights Market softness brings valuation gaps into focus Select ASX stocks show divergence from estimated worth Earnings outlook and revenue trends remain key drivers Recent movements across the Australian equity sp...

S&P/ASX 200 Index (ASX: XJO) healthcare shares are down 1.1% on Tuesday and down 36% over the past 12 months. The healthcare sector continues to battle significant headwinds, including a weaker US dollar, US tariffs, and higher labo...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Highlights Short interest highlights shifting market sentiment Multiple ASX 200 names dominate the list Sector-wide concerns driving cautious positioning High short interest across ASX 200 stocks highlights cautious market sentime...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Telix shares surge up to 9% after this morning’s surprise deal with Regeneron Relating to therapies not yet being developed by Telix, the compact includes a US$40 million upfront payment Oh baby! Genesis returns with improved Monash IVF o...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Highlights Healthcare sector coverage across Australian equity benchmarks spanning biotechnology, diagnostics, and medical technology Multiple healthcare entities represented across ASX 100, ASX 200, ASX 300, and All Ordinaries framewo...

The stem cell leader has outlined ambitious expansion plans at its New York investor confab Heart clinicians Wise up to EBR’s groundbreaking leadless pacing device You BARDA believe it: Avita scores a US$25.5 million burns deal    At its...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Koala Company (ASX:KOA) ripped out a fairly strong first week on the Australian market after floating on Tuesday, March 31, following an upswing that day with two more bumper jumps to settle ~$4/share into the Easter weekend. Listen to t...

Highlights Multiple ASX-listed companies trade near recent low levels. Sector-wide pressures influence stock movements across industries. Market participation reflects changing economic conditions. The Australian equit...

Highlights Healthcare stocks face heightened short-selling activity Sector weakness reflects shifting sentiment and company-specific factors Clinical updates and strategic moves shape outlook across key players Healthcare stocks f...

Highlights Small-cap segment reflects shifting participation across sectors. Selected companies drive movement within Small Ordinaries index. Broader market trends influence small-cap activity. Small Ordinaries activit...

Highlights • Healthcare stocks on the ASX reflect notable sector-wide activity. • Medical technology and biotech companies remain central to sector developments. • Market focus aligns with ongoing innovation across healthcare solutions...

Highlights • Healthcare companies remain active participants across Australian equities.• Companies such as CSL Limited (ASX:CSL) and Polynovo Limited (ASX:PNV) operate within specialised medical technology and biotechnology fields.• Sec...

Highlights Short interest trends reveal shifting sentiment across several ASX companies Declining bearish positions seen in a few heavily pressured businesses Fresh pessimistic bets emerge in technology, healthcare and servi...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Highlights Retail, healthcare, and travel technology firms drawing strong market focus Operational expansion and innovation shaping company outlooks Sector diversity reflecting evolving trends across the Australian market...

ASX healthcare sector falls 13.31% in February as benchmark ASX 200 up 4% Blood products and vaccines giant CSL weighed heavily on sector down 19.1% in February Rhythm Biosciences up 48% in February to be sector’s biggest gainer for the mo...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

February may have included Valentine’s Day, but investors didn’t show a great deal of love for our revenue-generating healthcare stocks Companies producing ambivalent results were whacked while the poor performers were hit even harder But...

Polynovo Ltd (ASX: PNV) shares were out of form on Monday and ended the day in the red. The ASX 300 stock fell 1.5% to 90.5 cents. This means that the medical device company's shares are now down approximately 50% since this time last year....

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

The ASX healthcare sector plunged 12% this week as a rough reporting season took casualties Biggest healthcare name CSL fell heavily on the back of the CEO’s exodus and H1 FY26 results Pro Medicus plummeted despite solid result, including...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

ASX healthcare sector rises 2.25% in January as benchmark ASX 200 up 1.78% Index largely supported by the sector’s largest stock CSL, up 5.1% in January Anteris and PYC announce monster capital raises with strong support from US investors...

The Perth drug developer is raising big bucks to fund four clinical programs to fruition Deals! Deals! Deals! Aussie biotechs show the world is their oyster LTR Pharma says its erectile dysfunction drug works with younger patients While...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

ASX gold stock Catalyst Metals Ltd (ASX: CYL) closed at $8.62 per share, down 8% on Friday, but is up 158% over the past 12 months. Catalyst Metals is a gold miner and explorer with an operational mine in Western Australia and a develop...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

ASX health sector up 0.53% for the week, while broader market rises 0.36% Companies start reporting quarterly results next week ahead of half-year reporting season Third US clinical site approved for Imricor’s VISABL‑AFL trial to support U...

Lynas Rare Earths Ltd (ASX: LYC) has been one of the ASX's biggest winners over the past year. But after a huge run, the stock has hit a speed bump today. At the time of writing, Lynas shares are down 6.39% to $15.24. The pullback come...

Shares in Polynovo Ltd (ASX: PNV) are trading lower today. This comes despite the medical device company delivering a solid half-year trading update just one day earlier. On Monday, the Polynovo share price finished almost flat, down ju...

Catalyst Metals Ltd (ASX: CYL) shares started the week with a bang. The ASX 200 gold stock surged 8% to a fresh record high of $9.73 on Monday but ending the session at $9.64. Why did this ASX 200 gold stock jump? Investors were buying the...

It was a disappointing start to the trading week for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Monday. After an extraordinarily positive week last week, which saw the markets rise every...

The S&P/ASX 200 Index (ASX: XJO) is having a poor start to the week. In afternoon trade, the benchmark index is down 0.4% to 8,867.7 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they ar...

Highlights Market positioning shifted quietly across energy, healthcare, and consumer names Resource-linked stocks reflected changing global demand signals Defensive and growth themes showed contrasting momentum Market...

AMP Ltd (ASX: AMP) Chief Economist Shane Oliver is expecting the Australian share market to deliver returns of 8% this year and for interest rates to remain on hold, in a new investment outlook for 2026 published this week. Dr Oliver sa...